These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508 [TBL] [Abstract][Full Text] [Related]
5. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907 [TBL] [Abstract][Full Text] [Related]
6. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period. Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803 [TBL] [Abstract][Full Text] [Related]
8. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Yehia M; Matheson PJ; Merrilees MJ; Beaumont BW; Pilmore HL Nephrology (Carlton); 2006 Jun; 11(3):261-6. PubMed ID: 16756643 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
11. Do we have to treat subclinical rejections in early protocol renal allograft biopsies? Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Lekovski Lj; Ivanovski N; Popov Z Transplant Proc; 2007 Oct; 39(8):2550-3. PubMed ID: 17954170 [TBL] [Abstract][Full Text] [Related]
12. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection. Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275 [TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection. Wagrowska-Danilewicz M; Danilewicz M Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789 [TBL] [Abstract][Full Text] [Related]
18. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome. Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142 [TBL] [Abstract][Full Text] [Related]